Monday - December 23, 2024

Pharmaceutical Composition Exhibiting Anti-Tumor Activity, Method for Treating Patient Suffering From Cancer and Method for Inhibiting Tumor Growth

ALEXANDRIA, Virginia, Nov. 19 -- GONGWIN BIOPHARM CO., LTD., Taipei, Taiwan has been assigned a patent (No. US 12144789 B2, initially filed Jan. 19, 2022) developed by five inventors Nanshan Zhong, Guangzhou, China; Longjiang Li, Chengdu, China; Chia-Shun Shih, Taipei, Taiwan; Lester J. Wu, Cape Coral, Florida; and Mao-Yuan Lin, Taipei, Taiwan, for "Pharmaceutical composition exhibiting anti-tumor activity, method for treating patient suffering from cancer and method for inhibiting tumor growth . . .

Information Request Form

Name:
Category that best fits the type
of business or agency you are
affiliated with:
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:
I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest.
If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method.
Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Copyright Targeted News Service 2024